AHA Urges the CMS to Consider Alternative Payment Solutions for CAR T Therapy

AHA writes to urge the Centers for Medicare & Medicaid Services to consider alternative payment solutions for Chimeric Antigen Receptor T-cell (CAR T) therapy.

View full details in the following letter. 

Related Resources

Testimony
Public
AHA Statement before the House Committee on Budget on Key Design Components and Considerations for Establishing a Single-Payer Health Care System
AHA Center for Health Innovation Market Scan
The days of shared-risk, value-based contracts (VBC) dominating health care are seemingly just around the corner. But that reality may not materialize as…
Special Bulletin
Member
The Centers for Medicare…
Advisory
Member
The Centers for Medicare…
Advisory
Member
The AHA released a detailed summary of the Centers for Medicare…
Advisory
Member
On April 18, the Centers for Medicare…